Your search history is turned on.
Date: April 24, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
ELIXXER LTD. FORM 58-101F2 CORPORATE GOVERNANCE DISCLOSURE (VENTURE ISSUERS) (For the Financial Year ended December 31, 2022) Elixxer Ltd. (the Corporation) is a venture issuer as defined under Regulation 58-101 Respecting Disclosure of Corporate Governance Practices (Reg. 58-101) and is disclosing its corporate governance practices...
ELIXXER LTD. FORM 52-110F2 AUDIT COMMITTEE DISCLOSURE BY VENTURE ISSUERS (For the financial year ended December 31, 2022) Elixxer Ltd. (the Corporation) is a venture issuer as defined under Regulation 52-110 Respecting Audit Committees (Reg. 52-110) and is disclosing its director and executive compensation in accordance with Form 52...
ELIXXER LTD. FORM 51-102F6V STATEMENT OF EXECUTIVE COMPENSATION (For the fiscal year ended December 31, 2022) Elixxer Ltd. (the Corporation) is a venture issuer as defined under National Instrument 51-102 Continuous Disclosure Obligations and is disclosing its director and executive compensation in accordance with Form 51- 102F6V Statem...
Date: November 24, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Stuart Adair, Chief Financial Officer of Elixxer Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Elixxer Ltd. (the issuer) for the interim period ended September 30, 2023. 2. No m...
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Ferras Zalt, Chief Executive Officer of Elixxer Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Elixxer Ltd. (the issuer) for the interim period ended September 30, 2023. 2. No mi...
ELIXXER LTD. MANAGEMENTS DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2023 and 2022 As at November 23, 2023 2 Managements Discussion and Analysis For the three and nine months ended September 30, 2023 and 2022 As at November 23, 2023 The following managements discussion and analysis (MD&A) of the results of ...
Financial statements of Condensed Interim Consolidated Financial Statements Elixxer Ltd. For the three and nine months ended September 30, 2023 and 2022 INDEX Condensed Interim Consolidated Statements of Financial Position 2 Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 3 Condensed In...
Date: November 9, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Quebec
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Stuart Adair, Chief Financial Officer of Elixxer Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Elixxer Ltd. (the issuer) for the interim period ended June 30, 2023. ...
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Ferras Zalt, Chief Executive Officer of Elixxer Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Elixxer Ltd. (the issuer) for the interim period ended June 30, 2023. ...
ELIXXER LTD. MANAGEMENTS DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2023 and 2022 As at November 8, 2023 2 Managements Discussion and Analysis For the three and six months ended June 30, 2023 and 2022 As at November 8, 2023 The following managements discussion and analysis (MD&A) of the results of operations and...